New and necessary in life sciences

Six innovation strategies from industry leaders

Download PDF Report

Download PDF report



Executive overview

Authors: Anthony Marshall

Connect with author:


, Research Director, IBM Institute for Business Value, IBM Global Business Services,
Heather Fraser

Connect with author:


, Global Lead for Healthcare and Life Sciences

The life sciences industry has been among the most successful and profitable industries for decades, with innovation central to this heritage. However, disruptive forces across life sciences, healthcare and technology are changing industry dynamics and creating emerging life sciences and healthcare ecosystems.

And yet, a substantial number of organizations are finding financial success even as they face turbulence. Set against these changing circumstances, few executives are confident about their organizations’ abilities to continue innovating successfully in the future; they realize that new innovation strategies are required.

How are organizations addressing the need for innovation, and how are leaders staying competitive? To learn more, the IBM Institute for Business Value (IBV) conducted the 2014 Life Sciences Innovation Survey of 750 industry leaders, including executives from pharmaceutical, biotech and diagnostics organizations, as well as academia.

Based on our analysis of study findings, we then discovered six innovation strategies that differentiate the most successful life sciences companies from others: viewing innovation as a portfolio, efficiently stopping unsuccessful innovation, embracing open innovation, participating in emerging markets, meeting patient expectations and diversifying growth initiatives.


Related reports

Disrupting drug discovery

To help accelerate drug discovery, leading organizations and researchers are turning to artificial intelligence (AI) because it can reveal hidden patterns in data.

A healthy outlook

Technological advancements are helping healthcare to become more personalized, cost-effective, scalable, and capable of achieving greater success outcomes than before.

Driving positive outcomes

Digital technologies are helping life sciences companies secure short-term finances and gain long-term industry benefits.

Loneliness and the aging population

Many diverse stakeholders can now help mitigate the impact of solitude and risks associated with loneliness that are especially detrimental to older adults.